Regulatory Milestone and Clinical Indications The US Food and Drug Administration (FDA) has granted regulatory clearance for two new indications... Read more
FDA Grants Dual Approvals for AstraZeneca and Daiichi Sankyo’s Enhertu in Early Breast Cancer
19/05/2026
Published by vivi
